top of page
  • Jonathan Poyer

AbbVie On an Acquisition Tear





Week Ending December 1st, 2023


  • Biotech: 4 Transactions (2 Follow-Ons and 2 PIPEs) totaling just over $900 Million

  • Med Tech: No Current Week Transactions


2023 YTD


  • 163 Biotech transactions totaling just under $25 Billion v. 2022: 150 Biotech transactions totaling just under $19 Billion

  • 18 Med Tech transactions totaling just over $1 Billion v. 2022: 10 Med Tech transactions just under $900 Million


December Major Transactions:


AbbVie acquired Cerevel Therapeutics - $8.7B / $45/share

Roche acquired Carmot Therapeutics - $2.7B


November Major Transactions:


AbbVie acquired Immunogen - $10.1B / $31.26/share

Astellas Pharma acquired Proprella Therapeutics - $175M

Ajinomoto acquired Forge Biologics - $554M


8 views0 comments

Comments


bottom of page